From Casetext: Smarter Legal Research

Abaxis, Inc. v. Cepheid

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN JOSE DIVISION
Jul 20, 2012
Case No.: 10-CV-2840-LHK (N.D. Cal. Jul. 20, 2012)

Summary

excluding an expert's opinions on the commercial success of products in a patent action because the witness was "an expert in pharmacy, not in sales, marketing, or consumer preferences and demand"

Summary of this case from Specialty Earth Scis., LLC v. Carus Corp.

Opinion

Case No.: 10-CV-2840-LHK

07-20-2012

Abaxis, Inc. Plaintiff-Counterdefendant, v. Cepheid, Defendant-Counterclaimant

Plaintiff Attorneys: Ricardo Rodriguez, Lam Nguyen Defendant Attorneys: Steven Carlson, Rebecca Grant, Jonathan Singer


CASE MANAGEMENT ORDER

Clerk: Martha Parker Brown
Reporter: Lee-Anne Shortridge

Plaintiff Attorneys: Ricardo Rodriguez, Lam Nguyen

Defendant Attorneys: Steven Carlson, Rebecca Grant,

Jonathan Singer

A further case management conference was held on July 19, 2012.

The Court held a hearing on Abaxis's motion for relief from Magistrate Judge Lloyd's April 9, 2012 order denying Abaxis's March 1, 2012 motion for leave to amend its infringement contentions, including its willfulness contentions. In the fall of 2011, the parties discussed the possibility of mutually granting each other leave to amend their respective infringement and invalidity contentions, but did not reach an agreement. In January 2012, Abaxis stipulated to leave for Cepheid to amend its invalidity contentions based on discovery that Abaxis produced on November 11, 2011, December 19, 2011, and January 4, 2012. However, Cepheid did not reciprocate when Abaxis on February 14, 2012 requested a stipulation as to Abaxis's infringement contentions. The Court affirmed Judge Lloyd's order denying Abaxis leave to amend its infringement contentions with discovery that Cepheid produced before February 1, 2012, but found clear error as to discovery Cepheid produced on or after February 1, 2012, including after the February 16, 2012 fact discovery cutoff. Cepheid should not be rewarded for its late production of discovery that even Cepheid believed was responsive to earlier Abaxis's discovery requests. Accordingly, the Court granted Abaxis leave to amend its infringement contentions, including its willfulness contentions, with discovery that Cepheid produced on or after February 1, 2012. This discovery also includes information about products produced by Cepheid's Generation 1 "Beadulator" process.

The Court set the following case schedule: DEADLINE TO FILE JOINT STATUS REPORT REGARDING POTENTIAL JURY TRIAL START DATE OF SEPTEMBER 21, 2012 is July 26, 2012. DEADLINE TO EXCHANGE DRAFTS OF JOINT PRETRIAL STATEMENTS AND MOTIONS IN LIMINE is August 7, 2012. DEADLINE TO MEET AND CONFER REGARDING SETTLEMENT, JOINT PRETRIAL STATEMENT, AND EXCHANGE OF PRETRIAL MATERIALS is August 8, 2012. DEADLINE TO LODGE AND SERVE JOINT PRETRIAL STATEMENT is August 15, 2012. Joint Pretrial Statement is limited to 25 pages. DEADLINE TO EXCHANGE EXHIBITS, SUMMARIES, CHARTS, AND DIAGRAMS TO BE USED AT TRIAL is August 20, 2012. DEADLINE TO FILE MOTIONS IN LIMINE is August 20, 2012.
Each party is LIMITED to 20 pages and up to 7 motions in limine.
DEADLINE TO FILE OPPOSITIONS TO MOTIONS IN LIMINE is August 22, 2012. DEADLINE TO FILE JURY VOIR DIRE QUESTIONS AND JOINT STIPULATED AND
DISPUTED JURY INSTRUCTIONS AND VERDICT FORM is August 22, 2012.
DEADLINE TO MAKE PRETRIAL DISCLOSURES is August 24, 2012. PRETRIAL CONFERENCE AND HEARING ON WILLFULNESS MOTION is August 29, 2012, at 2:00 p.m. DEADLINE TO FILE DEPOSITION AND DISCOVERY DESIGNATIONS is September 10, 2012. DEADLINE FOR DEFENDING PARTY TO SERVE OFFER OF JUDGMENT (PURSUANT TO FED. R. CIV. PROC. 68) is September 10, 2012. DEADLINE TO FILE OBJECTIONS AND COUNTERDESIGNATIONS TO DEPOSITION TESTIMONY is September 14, 2012. DEADLINE FOR PARTIES TO DELIVER 3 SETS OF PREMARKED EXHIBITS IN BINDERS TO COURTROOM DEPUTY is September 17, 2012. JURY TRIAL DATES are September 24, September 25, September 28, October 1, October 2, and October 5, 2012 at 9 a.m. in courtroom 8, 4th floor. The jury shall have 8 members. Each party is limited to 15 minutes of attorney voir dire and three preemptory challenges. During trial, each party is limited to 15 hours, including up to 45 minutes of opening statement.

IT IS SO ORDERED.

____________

LUCY H. KOH

United States District Judge


Summaries of

Abaxis, Inc. v. Cepheid

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN JOSE DIVISION
Jul 20, 2012
Case No.: 10-CV-2840-LHK (N.D. Cal. Jul. 20, 2012)

excluding an expert's opinions on the commercial success of products in a patent action because the witness was "an expert in pharmacy, not in sales, marketing, or consumer preferences and demand"

Summary of this case from Specialty Earth Scis., LLC v. Carus Corp.
Case details for

Abaxis, Inc. v. Cepheid

Case Details

Full title:Abaxis, Inc. Plaintiff-Counterdefendant, v. Cepheid…

Court:UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN JOSE DIVISION

Date published: Jul 20, 2012

Citations

Case No.: 10-CV-2840-LHK (N.D. Cal. Jul. 20, 2012)

Citing Cases

Specialty Earth Scis., LLC v. Carus Corp.

Just because Luster-Teasley has expertise with respect to the science and technology underlying the Licensed…

In re MacBook Keyboard Litig.

"Experts are not required to have previous experience with the product at issue[.]" Czuchaj v. Conair Corp.,…